Home / About ACCC / Awards / ACCC Innovator Awards / 2025 Winners / Wellspan Health Wellspan Cancer Institute

WELLSPAN HEALTH, WELLSPAN CANCER INSTITUTE

WellSpan Health, WellSpan Cancer Institute

Andrew Munchel, MSN, RN, OCN, CPHQ
Quality Program Administrator, Oncology Service Line
WellSpan Health, WellSpan Cancer Institute
York, Pennsylvania

Adopting Machine Learning-Enabled Decision Support to Improve Oncology End-of-Life Outcomes

Machine learning-enabled decision support helped this program integrate a 12-month mortality risk model into clinical workflows, reducing in-hospital mortality and healthcare costs while increasing palliative care utilization. Outcomes data show an 84% increase in palliative care referrals and a 14% decrease in in-hospital mortality among advanced cancer patients.

From the ACCCBuzz Blog

Adopting Machine Learning-Enabled Decision Support to Improve Oncology End-of-Life Outcomes

Adopting Machine Learning-Enabled Decision Support to Improve Oncology End-of-Life Outcomes

May 13, 2025

In this Q&A with WellSpan Cancer Institute, one of the six 2025 ACCC Innovator Award Winners, ACCCBuzz dives into the program's initiative that leverages machine learning-enabled decision support to improve end-of-life outcomes.

CANCER BUZZ Podcasts

Adopting Machine Learning-Enabled Decision Support to Improve Oncology End-of-Life Outcomes - [Mini Podcast] Ep 199

July 15, 2025

In this episode, CANCER BUZZ speaks with Andrew Munchel, MSN, RN, OCN, CPHQ, quality program administrator, oncology service line at WellSpan Health, WellSpan Cancer Institute about his program’s receipt of a 2025 ACCC Innovator Award. WellSpan Cancer Institute’s innovation, Adopting Machine Learning-Enabled Decision Support to Improve Oncology End-of-Life Outcomes, involved the implementation of the End-of-Life Care Index, a machine learning and cognitive computing model that predicts 12-month mortality risk, into the cancer program’s clinical decision support tool. Driven by a desire to address the underutilization of palliative care, Munchel will discuss how this implementation enhanced both the efficiency and effectiveness of WellSpan Cancer Institute’s care delivery.